Search
for

    Sort by

    Research 61–90 of 1000+

    1. Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options Expert Opinion on Therapeutic Targets · 2019 · 19 citations
    2. Spironolactone and XPB: An Old Drug with a New Molecular Target Biomolecules · 2020 · 18 citations
    3. Chapter 17. Selective androgen receptor modulators (SARMs) Annual Reports in Medicinal Chemistry · 2001 · 18 citations
    4. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study Archives of Cardiovascular Diseases · 2019 · 17 citations
    5. Hair follicles and their role in skin health Expert Review of Dermatology · 2006 · 16 citations
    6. Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors Psychoneuroendocrinology · 2018 · 14 citations
    7. Alcohol Exposure During Late Adolescence Increases Drinking in Adult Wistar Rats, an Effect that is not Reduced by Finasteride Alcohol and Alcoholism · 2012 · 12 citations
    8. Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review Journal of Medical Virology · 2021 · 11 citations
    9. Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases Current Medicinal Chemistry · 2016 · 11 citations
    10. Alopecia - the search for novel agents continues Expert Opinion on Therapeutic Patents · 1997 · 11 citations
    11. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    12. Neonatal allopregnanolone or finasteride administration modifies hippocampal K+ Cl− co-transporter expression during early development in male rats The Journal of Steroid Biochemistry and Molecular Biology · 2014 · 10 citations
    13. Treatment of androgen excess in females: Yesterday, today and tomorrow Gynecological Endocrinology · 1997 · 9 citations
    14. Treatment of hyperandrogenism in women Gynecological Endocrinology · 1996 · 8 citations
    15. Chapter 20. Pathogenesis and Treatment of Alopecias Annual Reports in Medicinal Chemistry · 1989 · 8 citations
    16. Chapter 23. Therapeutic Control of Androgen Action Annual Reports in Medicinal Chemistry · 1994 · 7 citations
    17. Differential impact of environmental factors on systemic and localized autoimmunity Frontiers in immunology · 2023 · 5 citations
    18. Secondary amenorrhea The Nurse Practitioner · 2017 · 4 citations
    19. The genetically programmed hair growth cycle and alopecia: what is there to know? Expert Review of Dermatology · 2006 · 3 citations
    20. Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy Frontiers in Immunology · 2026
    21. Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies Frontiers in Pharmacology · 2026
    22. An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of 5-alpha-dihydrotestosterone in human serum and plasma Clinical Chemistry and Laboratory Medicine (CCLM) · 2026
    23. Beyond Clinical Efficacy: A Literature Review on the Safety Challenges of Isotretinoin Therapy Quality in Sport · 2026
    24. SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA International Journal of Innovative Technologies in Social Science · 2025
    25. Adrenal causes of endocrine hypertension in childhood or adolescence Journal of Endocrinological Investigation · 2025
    26. Understanding Polycystic Ovary Syndrome Directory of Open access Books (OAPEN Foundation) · 2025
    27. The skin and obesity International Journal of Dermatology Venereology and Leprosy Sciences · 2025
    28. AN SYNOPTIC OVERVIEW ON AUTOIMMUNE DISORDERS AND ITS MANAGEMENT International Journal of Biology Pharmacy and Allied Sciences · 2022
    29. Alopecia Elsevier eBooks · 2018
    30. Efectos de la alteración de los niveles de allopregnanolona durante periodos críticos del neurodesarrollo en la vulnerabilidad al consumo de alcohol 2018